Neuroendocrine and hypothermic effects of 5-HT(1A) receptor stimulation with ipsapirone in healthy men: A placebo-controlled study

International Clinical Psychopharmacology

Volumn 13, Issue 1, 1998, Pages 23-32

  Cleare, A J ^a   Forsling, M ^b   Bond, A J ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Adrenocorticotrophin; Cortisol; Growth hormone; Ipsapirone; Oxytocin; Prolactin; Serotonin; Temperature

Indexed keywords

CORTICOTROPIN; HYDROCORTISONE; IPSAPIRONE; OXYTOCIN; PITUITRIN; PLACEBO; PROLACTIN; SEROTONIN 1A RECEPTOR;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG RESPONSE; HORMONE RELEASE; HUMAN; HUMAN EXPERIMENT; HYPOTHERMIA; MALE; NEUROHYPOPHYSIS; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; OXYTOCIN RELEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECEPTOR SENSITIVITY;

EID: 0031889381     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-199801000-00004     Document Type: Article

References (47)

1. Anderson IM, Cowen PJ, Grahame-Smith DG (1990). The effects of gepirone on neuroendocrine function and temperature in humans. Psychopharmacology 100:498-503.
2. Aulakh CS, Wozniak KM, Hill JL, Murphy DL (1988). Differential effects of long term antidepressant treatments on 8-OH-DPAT-induced increases in plasma prolactin and corticosterone in rats. Eur J Pharmacol 156:395-400.
3. Bagdy G, Calogero AE, Murphy DL, Szemeredi K (1989). Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats. Endocrinology 125:2664-2669.
4. Belment RJ, Brimble MJ, Forsling ML, Musabayane CT (1986). The influence of neurohypophysial hormones on renal function in the acutely hypophysectomied rat. J Physiol 381:439-452.
5. Beneke M, Wingender W, Horstmann R, Konrad-Dalhoff I, Weber H, Kuhllmann J, Schmidt BH (1992). Neuroendocrine effects of ipsapirone on the hypothalamo-pituitary-adrenal axis: CRF, ACTH and cortisol in healthy volunteers. Eur J Clin Pharmacol 42:163-169.
6. 1A agonist, on ACTH and PRL secretion in the rat. Neuroendocrinology 61:159-166.
7. Chaouloff F (1993). Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev 18:1-32.
8. Checkley SA (1980). Neuroendocrine tests of monoamine function in man: a review of basic theory and its application to the study of depressive illness. Psychol Med 10:35-53.
9. Cleare AJ, Bond AJ (1995). The effect of tryptophan depletion and enhancement on subjective and behavioural aggression in normal male subjects. Psychopharmacology 118:72-81.
10. Coccaro EF, Kavoussi RJ, Hauger RL (1995). Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder. Int Clin Psychopharmacol 10:177-179.
11. Delbende C, Delarue C, Lefebvre H, Bunel DT, Szafarczyk A, Mocaer E et al. (1992). Glucocorticoids, transmitters and stress. Br J Psychiatry 15 (suppl):24-35.
12. Di Renzo G, Amoroso S, Taglialatela M, Canzoniero L, Basile V, Fatatis A, Annunziato L (1989). Pharmacological characterization of serotonin receptors involved in the control of prolactin secretion. Eur J Pharmacol 162:371-373.
13. Di Sciullo A, Bluet Pajot MT, Mounier F, Oliver C, Schmidt B, Kordon C (1990). Changes in anterior pituitary hormone levels after serotonin 1A receptor stimulation. Endocrinology 127:567-572.
14. Gelfin Y, Lerer B, Lesch KP, Gorfine M, Allolio B (1995). Complex effects of age and gender on hypothermic, adrenocorticotrophic hormone and cortisol responses to ipsapirone challenge in normal subjects. Psychopharmacology 120:356-364.
15. 1A receptor subtype increases rat plasma ACTH concentration. Eur J Pharmacol 147:431-439.
16. 1A receptor activation in rats. Psychoneuroendocrinology 13:471-478.
17. Glaser T (1988). Ipsapirone, a potent and selective 5-HT1A receptor ligand with anxiolytic and antidepressant properties. Drugs of the Future 13:429-439.
18. Glaser T, Rath M, Traber J, Zillies K, Schleicher A (1985). Autoradiographic identification and topographical analyses of high affinity serotonin receptor subtypes as a target for the novel putative anxiolytic TVX Q7821. Brain Res 291:129-136.
19. Glennon RA, Dukat M (1995). Serotonin receptor subtypes. In: Bloom FE, Kupfer DJ (editors). Psychopharmacology. Fourth generation of progress. New York: Raven Press; pp. 415-429.
20. Goodall EM, Cowen PJ, Franklin M, Silverstone T (1993). Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers. Psychopharmacology 112:461-466.
21. Hillegaart V (1991). Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and medial raphe nuclei on core temperature in the rat. Psychopharmacology 103:291-296.
22. Kahn RS, Trestman R, Lawlor GS, Davidson M, Siever L (1994). Effects of ipsapirone in healthy subjects: a dose-response study. Psychopharmacology 114:155-160.
23. 1A receptor responsivity in anxiety disorders and depression. Prog Neuropsychopharmacol Biol Psychiatry 15:723-733.
24. Lesch KP, Rupprecht R, Poten B, Muller U, Sohnle K, Fritze J, Schulte HM (1989). Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans. Biol Psychiatry 26:203-205.
25. 1A receptor responsivity in unipolar depression. Evaluation of ipsapirone-induced ACTH and cortisol secretion in patients and controls. Biol Psychiatry 28:620-628.
26. 1A receptor activation in humans. Eur J Clin Pharmacol 39:17-19.
27. 1A). receptor activation: effects of 5-HT receptor and beta-adrenoceptor antagonists. J Clin Endocrinol Metab 70:670-674.
28. 1A agonist, 8-OH-DPAT, in male rats. Brain Res 630:148-156.
29. 1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry 36:300-308.
30. 2) agonists and antagonists on renin and corticosterone secretion. Neuroendocrinology 45:305-310.
31. Macs M, Meltzer HY (1995). The serotonin hypothesis of major depression. In: Bloom FE, Kupfer DJ (editors). Psychopharmacology. Fourth generation of progress. New York: Raven Press.
32. 1A) receptors in the rat hippocampus: electrophysiological evidence. Eur J Pharmacol 141:479-483.
33. Meltzer HY, Macs M (1994). Effect of pindolol on the L-5-HTP-induced increase in plasma prolactin and cortisol concentrations in man. Psychopharmacology 114:635-643.
34. Meltzer HY, Maes M (1995a). Effect of pindolol pretreatment on MK-212-induced plasma cortisol and prolactin responses in normal men. Biol Psychiatry 38:310-318.
35. Meltzer HY, Maes M (1995b). Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men. Psychiatry Res 58:89-98.
36. Nash JF, Meltzer HY (1989). Effect of gepirone and ipsapirone on the stimulated and unstimulated secretion of prolactin in the rat. J Pharmacol Exp Ther 249: 236-241.
37. O'Keane (1995). Dynamic serotonin neuroendocrine challenges in depressive disorders: what have we learnt. J Seroton Res 1:101-111.
38. Palazidou E, Stephenson J, Butler J, Coskeran P, Chambers S, McGregor AM (1995). Evidence for 5-hydroxytryptamine-1A receptor involvement in the control of prolactin secretion in man. Psychopharmacology 119:311-314.
39. Park SB, Cowen PJ (1995). Effect of pindolol on the prolactin response to d-fenfluramine. Psychopharmacology 118:471-474.
40. 1A receptor challenge in major depression and suicidal behavior. Pharmacopsychiatry 2:91-92.
41. Reist C, Helmeste D, Albers L, Chay H, Tang SW (1996). Serotonin indices and impulsivity in normal volunteers. Psychiatry Res 60:177-184.
42. Saydoff JA, Rittenhouse PA, van de Kar LD, Brownfield MS (1991). Enhanced serotonergic transmission stimulates oxytocin secretion in conscious male rats. J Pharmacol Exp Ther 257:95-99.
43. Seletti B, Benkelfat C, Blier P, Annable L, Gilbert F, de Montigny C (1995). Serotonin-1A receptor activation by flesinoxan in humans. Body temperature and neuroendocrine responses. Neuropsychopharmacology 13:93-104.
44. Simonovic M, Gudelsky GA, Meltzer HY (1984). Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion. J Neural Transm 59:143-149.
45. Smith CE, Ware CJ, Cowen PJ (1991). Pindolol decreases prolactin and growth hormone responses to intravenous L-tryptophan. Psychopharmacology 103:140-142.
46. 2 antagonist on prolactin secretion. Neuropharmacology 28:299-305.
47. Van de Kar LD, Rittenhouse PA, Li Q, Levy AD, Brownfield MS (1995). Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Brain Res Bull 36:45-50.